当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 现金流量表

振东制药

(300158)

  

流通市值:44.11亿  总市值:44.23亿
流通股本:10.03亿   总股本:10.05亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金597,926,743.453,319,611,511.922,479,959,642.531,694,160,759.89
收到的税费返还2,202,225.4418,807,255.6918,110,70013,494,614.07
收到其他与经营活动有关的现金2,755,281.946,342,746.4237,318,734.3826,155,200.36
经营活动现金流入的平衡项目0000
经营活动现金流入小计602,884,250.793,384,761,514.032,535,389,076.911,733,810,574.32
购买商品、接受劳务支付的现金266,383,537.071,578,892,269.371,154,324,604.98816,326,119.68
支付给职工以及为职工支付的现金105,579,509.57490,614,808.7365,322,889243,726,295.36
支付的各项税费30,713,845.79202,215,937.81138,552,983.31100,398,715.99
支付其他与经营活动有关的现金530,217,295.531,262,860,751.24987,961,393.77604,899,134.22
经营活动现金流出的平衡项目0000
经营活动现金流出小计932,894,187.963,534,583,767.122,646,161,871.061,765,350,265.25
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-330,009,937.17-149,822,253.09-110,772,794.15-31,539,690.93
二、投资活动产生的现金流量:
收回投资收到的现金1,248,499,0006,346,477,714.165,014,359,360.363,764,905,417.91
取得投资收益收到的现金4,157,586.5646,968,868.9735,974,292.7628,984,750.03
处置固定资产、无形资产和其他长期资产收回的现金净额-7,770,836.68,833,451.226,597,975.6
处置子公司及其他营业单位收到的现金净额-988,384.11,032,739.031,032,741.11
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,252,656,586.566,402,205,803.835,060,199,843.373,801,520,884.65
购建固定资产、无形资产和其他长期资产支付的现金26,579,151.77298,476,228.4232,144,683.74141,252,692.71
投资支付的现金967,003,0006,064,217,554.345,001,922,654.683,804,888,580.06
投资活动现金流出的平衡项目0000
投资活动现金流出小计993,582,151.776,362,693,782.745,234,067,338.423,946,141,272.77
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额259,074,434.7939,512,021.09-173,867,495.05-144,620,388.12
三、筹资活动产生的现金流量:
取得借款收到的现金-38,109,647.779,310,461.5813,986,585.03
收到其他与筹资活动有关的现金21,766,957.9991,850,241.3161,065,477.5432,414,909.65
筹资活动现金流入平衡项目0000
筹资活动现金流入小计21,766,957.99129,959,889.0870,375,939.1246,401,494.68
偿还债务支付的现金150,00053,350,00050,200,00050,200,000
分配股利、利润或偿付利息支付的现金82,462.2584,652.53505,767.83421,473.14
支付其他与筹资活动有关的现金61,638,214.31170,518,396.79155,277,181.63141,348,485.14
筹资活动现金流出平衡项目0000
筹资活动现金流出小计61,870,676.51224,453,049.32205,982,949.46191,969,958.28
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-40,103,718.52-94,493,160.24-135,607,010.34-145,568,463.6
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-111,039,220.9-204,803,392.24-420,247,299.54-321,728,542.65
加:期初现金及现金等价物余额558,015,272.49762,818,664.73762,818,664.73762,818,664.73
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额446,976,051.59558,015,272.49342,571,365.19441,090,122.08
补充资料:
净利润--1,332,939,095.45-28,101,714.35
资产减值准备-290,875,553.09-23,352,445.59
固定资产和投资性房地产折旧-92,889,781.6-48,293,306.5
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-92,889,781.6-48,293,306.5
无形资产摊销-20,679,341.22-9,737,940.33
长期待摊费用摊销-5,475,613.69-1,758,006.49
处置固定资产、无形资产和其他长期资产的损失--11,256,735.65--11,623,971.48
固定资产报废损失-712,593.1-740,830.75
公允价值变动损失-139,440,121.7--6,873,773.94
财务费用-3,900,426.39-2,077,790.47
投资损失--41,972,827.58--28,914,063.76
递延所得税--3,275,343.82-2,339,411.46
其中:递延所得税资产减少--3,957,060.89-328,948.11
递延所得税负债增加-681,717.07-2,010,463.35
存货的减少-176,504,093.1-57,534,795.5
经营性应收项目的减少-114,995,475.58--25,075,009.15
经营性应付项目的增加-270,363,450.63--131,455,071.19
其他-122,768,092--1,534,042.85
现金的期末余额-558,015,272.49-441,090,122.08
减:现金的期初余额-762,818,664.73-762,818,664.73
公告日期2025-04-212025-04-212024-10-242024-08-27
审计意见(境内)标准无保留意见
TOP↑